NCT07401381
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07401381
Title A Study to Compare the Steady-State Bioavailability of Injectable Letrozole SIE and Oral Letrozole in Post-Menopausal Women With Hormone Receptor Positive Early Breast Cancer (SIE-1)
Acronym SIE-1
Recruitment Recruiting
Gender female
Phase Phase I
Variant Requirements No
Sponsors Rovi Pharmaceuticals Laboratories
Indications
Therapies
Age Groups: senior | adult
Covered Countries ESP


No variant requirements are available.